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ABSTRACT
Objectives: To demonstrate the contribution of
community pharmacy from NHS 111 referrals out of
hours (OOH) for emergency supply repeat medication
requests via presentation of service activity, community
pharmacist feedback and lean thinking transformation.
Design: Descriptive service evaluation using routine
service activity data over the pilot period; survey of
community pharmacists, and service redesign through
lean thinking transformation.
Setting: North East of England NHS 111 provider and
accredited community pharmacies across the North
East of England.
Participants: Patients calling the North East of
England NHS 111 provider during OOH with
emergency repeat medication supply requests.
Interventions: NHS 111 referral to community
pharmacies for assessment and if appropriate, supply
of emergency repeat medication.
Main outcome measures: Number of emergency
repeat medication supply referrals, completion rates,
reasons for rejections, time of request, reason for
access, medication(s), pharmaceutical advice and
services provided. Secondary outcomes were
community pharmacist feedback and lean thinking
transformation of the patient pathway.
Results: NHS 111 referred 1468 patients to 114
community pharmacies (15/12/2014–7/4/2015). Most
patients presented on Saturdays, with increased activity
over national holidays. Community pharmacists
completed 951 (64.8%) referrals providing 2297
medications; 412 were high risk. The most common
reason for rejecting referrals was no medication in
stock. Community pharmacists were positive about
the provision of this service. The lean thinking
transformation reduced the number of non-added
value steps, waits and bottlenecks in the patient
pathway.
Conclusions: NHS 111 can redirect callers OOH from
urgent and emergency care services to community
pharmacy for management of emergency repeat
medication supply. Existing IT and community
pharmacy regulations allowed patients to receive a
medication supply and pharmaceutical advice.
Community pharmacists supported integration into the
NHS OOH services. Adopting lean thinking provided a
structured framework to evaluate and redesign the
service with the aim to improve effectiveness and
efficiency.
INTRODUCTION
NHS 111 was established as the new public
telephonic access route to the NHS in Easter
2013. It replaced NHS Direct and differed in
key areas such as a reduction in clinical
input in assessments; did not aim to promote
self-care; met a narrower range of patient
needs and used clinical content that was new
to the urgent care setting.1
The NHS Pathways system is the compu-
terised decision support software (CDSS)
used by NHS 111 non-clinical call handlers
to assess all in-coming calls. This platform
incorporates a Directory of Services (DoS),
which is a single source of information that
identifies local services.2 It has been sug-
gested that the software responds well to
Strengths and limitations of this study
▪ The study reports on the routine service data col-
lection carried out during the service implemen-
tation and delivery.
▪ This study demonstrates best practice to service
designers and developers in employing NHS
guidance on lean thinking transformation when
evaluating and developing services to improve
efficiency and effectiveness of services.
▪ A process evaluation is required to fully investi-
gate and understand the true value of this
service within the wider NHS.
▪ Patient perspectives of this service should be
collected to evaluate the impact on the accept-
ability, and access and quality of care.
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emergency cases such as chest pain or breathing difficul-
ties but appears less able to support call handlers to
signpost callers to an appropriate level of non-urgent
care. As a result, callers are directed to other face-to-face
NHS services listed within the DoS rather than provided
with support to care for themselves.1 The evaluation of
the NHS 111 pilot sites demonstrated that only 8% of
patients using the service were given advice to look after
themselves without the need for onward referral. This
CDSS has also been determined as more risk averse
than the previous CDSS used by NHS Direct and was
not intended for use in an urgent care setting.1
The evaluation of the NHS 111 pilot services was
unable to define the likely impact of NHS 111 on the
wider NHS urgent and emergency care system.3
However, early data following the national launch sug-
gested that urgent and emergency care services were
being adversely affected by the increased demand.1
A high demand on the urgent and emergency care
services out of normal opening hours (evenings, week-
ends and holiday periods) with record numbers of calls
made to NHS 111 during December 2014 was identi-
fied.4 5 One factor contributing to this workload was
callers’ requests for missed or lost repeat medication
that comprised 15% of calls at busy times, for example,
out of normal opening hours, bank holidays and
weekends.6
Community pharmacists are legally permitted under
the Human Medicines Regulations to provide emer-
gency supplies of prescription-only medicines (POMs) at
the request of the patient without a prescription. The
legislation requires that pharmacists clinically assess
patient need and act according to their professional
judgement.7 Community pharmacy is a highly accessible
point of healthcare for the public, as ∼90% of the popu-
lation can access a community pharmacy within a
20 min walk and no appointment is required.8 In add-
ition, awareness of the potential contribution of pharma-
cists to urgent and emergency care has increased. The
NHS Five Year Forward View stressed the need to make
greater use of pharmacists.9 The Royal Pharmaceutical
Society (RPS), the professional representative body for
pharmacy, policy document, ‘Shaping pharmacy for the
future: improving urgent and emergency care through
better use of pharmacists’ recommended that the
national contract by NHS England for community phar-
macists should provide a common ailment service; a
pharmacist should be incorporated into Accident and
Emergency departments to manage medication-related
issues and that pharmacists are a referral option within
NHS 111 to support urgent and emergency care, par-
ticularly for common ailments and emergency supplies
of medicines.10
In November 2014, an NHS Community Pharmacy
Emergency Repeat Medication Supply Service
(PERMSS) was commissioned by NHS England North,
as a pilot working across Cumbria and the North East,
and supported by local clinical commissioning groups
(CCGs), running from 15 December 2014 to 7 April
2015. The service proposal was produced by a project
team consisting of members from the Local Pharmacy
Network (LPN), Commissioning Support Unit 111
Directory of Service and NHS England. The purpose of
this scheme was to enable patients calling NHS 111 out
of hours (OOH) with requests for repeat medication
emergency supplies to be directed to an open commu-
nity pharmacy where they could obtain an emergency
medication supply before their next dose. NHS 111 fol-
lowed standard procedures entering patient details into
the NHS Pathways CDSS but also used an information
technology (IT) referral platform, PharmOutcomes, a
web-based system collating information and facilitating
management of local service provision.11 The service
specification12 was circulated to all community pharma-
cies (n=711) across the North East. An information
sheet of frequently asked questions was disseminated to
all confirmed, eligible community pharmacy providers.
A short period of testing preceded service launch.
SERVICE INTERVENTION FOR NHS 111 REFERRED
PATIENTS
The service intervention was designed so that patients
making a call to NHS 111 OOH talked with a call
handler who used the CDSS standardised format of
questioning to arrive at an appropriate recommendation
for the patient. The specified OOH times during this
evaluative period was defined as Monday to Friday
between 18:30 and 08:00, weekends (Friday to Monday
between 18:30 and 08:00), Christmas Eve and New year’s
eve between 18:00 and 08:00 and at any time on speci-
fied days (Christmas day, Boxing day, New Year’s day,
Easter Friday and Easter Monday). NHS Pathways was
adapted so that emergency supply requests for repeat
medications would alert the call handler to refer the
patient to a community pharmacy rather than the
default General Practitioner (GP) OOH option. The
DoS provided the contact details of the nearest commu-
nity pharmacies open at the time and accredited to
provide PERMSS allowing the patient to select and
choose where the referral should be sent. Call handlers
then duplicated the patient personal details and missing
medications onto PharmOutcomes. At the end of the call,
this was then automatically sent to the selected commu-
nity pharmacy. Patients were advised to visit that commu-
nity pharmacy with evidence of their repeat medication,
for example, a repeat prescription request form, a
recently dispensed, labelled empty box of medication, a
recent GP letter or any other evidence that demonstrated
the medication was regularly prescribed. Community
pharmacists could then check PharmOutcomes to
retrieve the referral and contact the patients using the
details provided to clinically assess their need for a
supply. In some cases, patients could present at the com-
munity pharmacy before the community pharmacist
had checked PharmOutcomes, at which point the
2 Nazar H, et al. BMJ Open 2016;6:e011269. doi:10.1136/bmjopen-2016-011269
Open Access
 o
n
 31 January 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-011269 on 26 August 2016. Downloaded from 
community pharmacist would access the referral and
carry out the clinical assessment for medication supply.
This was followed by one of three outcomes:
▸ An emergency supply was made, in accordance with
the Human Regulations 20127 as no further clinical
advice was required and the POM was available in the
community pharmacy;
▸ The patient was advised to try another pharmacy
because, although no further clinical advice was
required, the POM was unavailable at the community
pharmacy;
▸ The patient was advised to contact another appropri-
ate healthcare service, for example, NHS 111 or a
walk-in centre because further clinical advice was
needed.
When an emergency supply was made, the community
pharmacist provided up to seven days’ supply, except
where it was not possible to dispense such volumes, for
example, inhaler, creams. In such cases, the smallest
pack size was dispensed. The regulations also prevent
emergency supply of Schedule 1, 2 or 3 controlled drugs
with the exception of phenobarbitone or phenobarbit-
one sodium for epilepsy.7 Patients who were exempt for
prescription payment received the medications free of
charge, while those not exempt paid the standard pre-
scription charge (£8.20). A professional fee linked to
the number of items supplied (£10+£2 for each add-
itional item) together with reimbursement of the cost of
the medicine (Drug Tariff prices plus VAT) was paid for
each emergency supply.
The supply was recorded in accordance with the usual
procedure within each community pharmacy. A record
of this supply was also made in PharmOutcomes, detail-
ing patient name, address, verbal consent for supply,
medication(s) supplied, nature of emergency, evidence
provided and if further pharmaceutical advice or service
was needed. A copy of the record was sent to the
patient’s GP using the PharmOutcomes email notifica-
tion facility. This included any relevant concerns, advis-
ory notes or issues identified. Further patient
pharmaceutical advice could have consisted of effective
medicines management, prescription request process
and/or medicines reconciliation. Additional services
that could also have been provided were a Medicines
Use Review (MUR) or consent obtained for repeat
dispensing.
Community pharmacists were then required to disclose
the final result of the referral on PharmOutcomes as
outlined below:
▸ Accepted: the referral was acknowledged and the
community pharmacist followed-up by contacting the
patient;
▸ Completed: the referral was acknowledged, actioned
and resulted in an emergency supply medication
being issued to the patient;
▸ Rejected: the referral was acknowledged and rejected.
An open box was provided for community pharma-
cists to record reasons for rejection.
If a community pharmacist had not acknowledged the
referral in PharmOutcomes nor registered any action
taken, then the status of that referral remained recorded
as ‘referred’ on the system.
LEAN THINKING TRANSFORMATION OF PERMSS
At the end of the pilot, the project management group
used the service evaluation data to inform redesign of
the service to reduce reported problems and maximise
benefits. The aims were to:
▸ Redesign the patient pathway for NHS 111 referred
patients using lean thinking transformation to dem-
onstrate efficiency and quality of the redesigned
service. This revised version of PERMSS would then
be proposed to the local CCG Forum for recommis-
sioning in the region.
▸ Develop a pathway template that would be transfer-
able and allow reproducibility in other healthcare
localities.
The lean concept emphasises a systemic, holistic view
of process improvement to avoid improvement at sub-
processes that shift problems to adjacent subprocesses.
Instruments of lean thinking have been applied in hos-
pitals to reduce waste in resources, waiting times and
improve productivity.13 14 The NHS Institute for
Innovation and Improvement proposes a range of bene-
fits using the approach of process mapping of a patient
journey as shown in box 1.15
Hydes et al identified that employment of lean think-
ing transformation can improve clinical processes to
positively influence patients’ evaluation of their health-
care experience. Other benefits related to economic
benefits to healthcare organisations, such as reduced
staffing requirements; increased performance, for
example, patient flow and reduced administration costs;
improved engagement from staff with more efficient and
appropriate use of their time and skill mix.13
This study aimed to demonstrate the contribution of
community pharmacy OOH to NHS 111 callers requir-
ing repeat medication supplies via the evaluation the
Community PERMSS. The activities underpinned by the
concept of lean thinking were undertaken at the end of
Box 1 Benefits of process mapping
▸ A starting point for an improvement project specific for your
own place of work.
▸ Creating a culture of ownership, responsibility and account-
ability for your team.
▸ Illustrates a patient pathway or process, understanding it from
a patient’s perspective.
▸ An aid to plan changes more effectively.
▸ Collecting ideas, often from staff who understand the system
but who rarely contribute to change.
▸ An interactive event that engages staff.
▸ An end product (a process map) that is easy to understand
and highly visual.
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the pilot period to review and redesign the service with
the aim to maximise clinical efficacy and efficiency by
eliminating ineffective and unnecessary activity.
METHODS
Service activity
Service activity, with patient identifiable information
removed, was automatically sent electronically as an
Excel spreadsheet via email from PharmOutcomes to
the independent evaluator (HN) at the end of the evalu-
ative period. However, patient age and postcode were
included in this data set. Extracted data from this data
sheet related to:
▸ Volume and times of day and week of calls to NHS
111 regarding missing medication that were referred
to community pharmacy;
▸ Outcome of that referral by the community pharmacy;
accepted, completed, rejected or remain referred;
▸ The reasons, where provided, for rejected referrals.
PharmOutcomes also collected data on supplies made
in community pharmacy as a consequence of completed
referrals. These data related to reasons for supply; evi-
dence provided to support supply; medication supplied
categorised according to British National Formulary
(BNF) chapters;16 identification of high-risk medications
according to the Patient Safety First Campaign 200817
(specifically opiates, insulin, anticoagulants, antipsycho-
tics, Non-steroidal anti-inflammatories (NSAIDs) and
diuretics) and the number of additional services and/or
pharmaceutical advice provided were recorded.
The North East Ambulance Service that manages the
NHS 111 call line provided average call handling times
of the 4 months preceding the service (August–
December 2014) and the average call handling times in
the months where the service was being provided
(December 2014–March 2015).
Additionally, NHS North England Commissioning
Support Unit provided the average ‘did not attend’
(DNA) rate of callers to NHS 111 provided with GP
OOH appointments within all participating CCGs
during 2014. This figure was used as a comparator to the
DNA rate of referred patients to community pharmacy.
Cost comparison of PERMSS to default OOH services
A cost comparison was carried out; however, as health
benefits were not included, a comparative evaluation of
costs and benefits, for example, cost-effectiveness or
cost–benefit analysis, was not performed. The costs of
the community pharmacy provisions of emergency sup-
plies were compared with the costs that could have been
incurred if the patient had accessed a GP OOH service
as had been the default NHS 111 recommendation
prior to the service pilot. The GP OOH service was a
block contract with no individual cost per consultation.
So an estimated cost per individual consultation was cal-
culated by dividing the cost of the block contract by the
activity within the region provided by the North of
England Commissioning Support Unit. Calls to NHS 111
cost £8 per call3 and therefore present an additional
cost. The costs were calculated based on the evaluative
period and also projected annual costs.
Community pharmacist feedback
The project team designed an electronic questionnaire
and circulated it within the local HealthWatch group
and the LPN to test for face validity and to provide any
comments and approval. The semi-structured question-
naire asked community pharmacists to provide feedback
on their understanding and support of the service.
Specifically, pharmacists were asked if requests for emer-
gency supply of medicines should be managed by com-
munity pharmacists and how well this service aligned to
their current role and responsibilities. Pharmacists were
asked on the perceived appropriateness of referral from
NHS 111; the appropriateness of PharmOutcomes as the
platform for this referral and whether the service could
be accommodated within the current community phar-
macy daily activity. Pharmacists were also asked how this
service contributed to workload, impact on consultation
time and their satisfaction with the reimbursement
process. Finally, pharmacists were asked how supportive
they were to providing such a service and if any service
improvements were required.
This electronic survey was circulated via PharmOutcomes
between 5 January and 7 April 2015. An email message
from the Local Pharmacy Committees requesting pharma-
cists complete the survey was sent on 5 January.
The anonymised community pharmacist feedback was
sent electronically as an Excel spreadsheet to the inde-
pendent evaluator (HN) via email from PharmOutcomes
at the end of the evaluation period.
Discussion within the project team and on consult-
ation of the NHS Health Research Authority guidance18
identified the study components to be either audit or
service evaluation and therefore ethical approval was not
required.
Lean thinking transformation of PERMSS
Preparation and planning
The project management team decided that a Kaizen
workshop, a multidisciplinary meeting of representative
stakeholders, was an appropriate technique for carrying
out the lean thinking transformation of the service
redesign. The design of the 2-day event was guided by
the NHS Modernisation Agency guide to Process
mapping, analysis and redesign.15 The event took place on
23–24 June 2015, 2 months after the end of the PERMSS
pilot. The venue was a neutral off-site environment to
prevent participants being distracted and coming in
and out of the workshop activities. A list of the stake-
holders who attended is included in online supplemen-
tary file 1. An evaluative report containing service
activity, patient feedback, community pharmacist feed-
back and NHS 111 call handler feedback was circulated
to all participants a week before the event.
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Data collection, mapping the information, analysing the data
and problem solving and redesigning the patient journey
During the 2-day Kaizen workshop, the value-stream
mapping (process mapping exercise) of the current
state of the PERMSS was produced by all stakeholders.
This process charted the patient journey from NHS 111
referral to a patient’s exit from the service having
received or not received a supply of their repeat medica-
tions. This mapped out journey was also analysed during
the workshop to identify problems such as non-added
value, waits or bottlenecks as recommended by Trebble
et al.19 On the basis of this exercise, the team of stake-
holders identified priorities in streamlining the pathway.
This was followed by the team redesigning the patient
journey as a future state map to increase activities that
added value and elimination of those that were waste.
RESULTS
Service activity
Over the evaluative period, 1468 patients accessed NHS
111 for requests for emergency supplies of their repeat
medication and were referred onto a community phar-
macy. The service was provided to NHS 111 referred
patients OOH by pharmacists at 114 (52%) community
pharmacies. The largest number of referrals occurred
within the first week of April (1st–7th). Table 1 shows
the number of patients accessing this service over the
evaluative period, the age of patients requiring emer-
gency repeat medication supplies and reasons for the
requests.
Of these referrals, 64.8% (n=951) were completed, of
which 92.4% (n=879) patients were entitled to exemp-
tion or prepayment. The majority of these referred
patients (58.5%, n=556) used an empty pack of previ-
ously dispensed medication as evidence of repeat supply.
A further 20.9% (n=199) presented a prescription
request form, 4.5% (n=43) of patients directed the
pharmacist to the pharmacy held patient medication
record and 2.4% (n=23) provided a GP letter. The
remaining 13.7% (n=130) patients used other forms of
evidence, for example, a previously dispensed Medidose
box or a Medication Adherence Record sheet. Patients
who received an emergency supply were also provided
with advice on effective medicines management (51.5%,
n=583); medicines reconciliation (32.9%, n=373); pre-
scription request process (9.5%, n=107), and 6% (n=68)
of patients were advised on other issues, for example,
adherence to medication, home delivery service. The
vast majority of patients (97.3%, n=925) were not pro-
vided with an additional pharmaceutical service as it was
considered unnecessary. However, 5 patients received an
MUR (0.5%), 8 patients signed up for the repeat dis-
pensing service (0.8%) and a further 13 patients (1.4%)
received other services, for example, smoking cessation
advice, influenza jab.
The remainder of the referrals were either not
actioned (remained referred) (15.5%, n=228); accepted
but not completed (5.8%, n=85) or rejected (13.9%,
n=204). Table 2 shows the reasons for rejections. No
stock being available was the most common reported
explanation for rejecting a referral (28.9%, n=59). In
66.1% (n=39) of cases where no stock was available, no
further action was recorded by the pharmacist. However,
in some instances, patients were referred back to NHS
111 (13.6%, n=8), another pharmacy (13.6%, n=8) or to
the hospital (1.7%, n=1). Three of the medications
(5.1%) were not in stock because they were a special for-
mulation that required specific manufacturing and had
to be ordered in advance of supply (usually 5 working
days).
Of the 951 NHS 111 referred patients who had ‘com-
pleted’ referrals, 2297 medicines were supplied, an
average of 2.4 medicines per patient, with the range in
number of medicines supplied from 1 to 9. Table 3
shows the BNF16 classification of these medicines and
the frequency of high-risk medications in accordance
with the Patient Safety First campaign.17
Table 1 The frequency of referrals made by NHS 111 to
community pharmacies, the characteristics of the patient
requiring an emergency supply and the reason for their
request (n=1468)
Characteristics of emergency
supply request
Number of
patients (%)
Access by month
December 2014 (15th–31st) 193 (13.1)
January 2015 (1st–31st) 274 (18.6)
February 2015 (1st–28th) 252 (17.1)
March 2015 (1st–31st) 268 (18.3)
April 2015 (1st–7th) 481 (32.7)
Access by day
Sunday 223 (15.2)
Monday 106 (7.2)
Tuesday 43 (2.9)
Wednesday 42 (2.8)
Thursday 77 (5.2)
Friday 306 (20.8)
Saturday 671 (45.7)
Age of patient (years)
<13 120 (8.1)
13–19 37 (2.5)
20–29 179 (12.1)
30–39 140 (9.5)
40–49 142 (9.6)
50–59 201 (13.6)
60–69 192 (13.0)
≥70 457 (31.0)
Reason for emergency supply request
Ran out of medicines 1065 (72.7)
GPs closed 187 (12.8)
Lost medication 58 (3.9)
Prescription not ready at the GP surgery 23 (1.5)
Acute presentation 4 (0.2)
Other 128 (8.7)
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The North East Ambulance Service provided data to
demonstrate that the average call handling time
between August and December 2014 was 6 min 31 s
(range, 6 min 12 s to 6 min 40 s). Within the evaluative
period, the average call handling time increased to
10 min 24s (range, 9 min 46 s to 11 min 6 s). This was
difference of 4 min 12 s, a 64% increase in call duration.
The average DNA rate of callers to NHS 111 provided
with GP OOH appointments within all participating
CCGs during 2014 was 5.56%. Data were provided by
NHS North England Commissioning Support Unit.
Cost comparison
Each patient received an average of 2.4 medications, and
therefore the average PERMSS cost was £12.80. For the
951 patients receiving a supply via PERMSS, the cost in
reimbursement for the community pharmacist for the
consultation was estimated to be £12 172.80. The esti-
mated cost of GP OOH via NHS 111 at £96 (GP OOH)+
£8 (NHS 111 call) was £98 904, eight times the cost for
supplies made via PERMSS.
Community pharmacist feedback
Of the 316 community pharmacists who were accredited
to undertake this service, 221 (70% response rate) com-
pleted the questionnaire and the responses of which are
displayed in table 4.
A few community pharmacists disagreed or strongly
disagreed that improvements to the service were
required (19%, n=42). However, 44% (n=97) identified
improvements were required, and 37% (n=82) were
unsure. Problems with the service related to referrals
being made when community pharmacies were shut
(n=32), or during normal GP opening times when
patients could access a prescription to cover a medica-
tion supply (n=27), or rejections being made because of
lack of stock (n=34). Some pharmacists (n=14) asked for
call handlers to have more information and training
about medications that can and cannot be issued as an
emergency supply through this service, for example,
acute medications, medications that have a high risk of
abuse (eg, hypnotics) and controlled drugs. It was also
identified that more accurate information of pharmacy
opening times should be held by NHS 111 (n=13).
Thirty suggestions related to the addition of a notifica-
tion in the form of an email or a text message to inform
the pharmacist that a referral had been made by NHS
111 via PharmOutcomes.
Community pharmacists (47%, n=104) also identified
that further PharmOutcomes training was required to
ensure that resident and locum pharmacists would know
how to use the system and check for referrals. Training
about the current emergency supply regulations (30%,
n=66) and increasing pharmacist capacity (16%, n=35)
were also suggested as facilitators for operating this
service.
Lean thinking transformation of PERMSS
Current state PERMSS patient pathway
There were 23 individual steps of the current patient
pathway identified from the value stream map produced
from the Kaizen workshop (shown in online
Table 2 The reasons provided by community pharmacists
for rejecting a NHS 111 referral
Reasons for rejections (n=204, 14%)
Medication not in stock 59 (28.9)
Patient did not attend 57 (27.0)
Error in referral information entered by call
handler
28 (13.7)
Clinically inappropriate to supply* 20 (9.8)
Patient received supply elsewhere 14 (6.9)
No evidence provided by the patient 6 (2.9)
Duplicate referral by NHS 111 6 (2.9)
Supplied under normal emergency supply
procedure†
4 (2.0)
No reason specified 10 (4.9)
*For example, an acute medication (eg, antibiotic) or controlled
drug is required by the patient. This service only allows for the
supply of repeat medications and does not allow the supply of
controlled drugs apart from the exceptions described above.
†The community pharmacist does not check for any notification of
a referral on PharmOutcomes before undertaking the consultation
with the patient and providing a medication as per the standard
emergency supply regulations. Therefore no entry onto
PharmOutcomes was made for remuneration.
Table 3 The medicines supplied through PERMSS to
NHS 111 referred patients as British National Formulary
6816 classification and high risk drug as classified by the
Patient Safety First campaign 200817
Classification of medicine
Number (%)
(n=2297)
BNF classification
Central nervous system 741 (32.3)
Cardiovascular 618 (26.9)
Endocrine 269 (11.7)
Gastrointestinal 182 (7.9)
Respiratory 140 (6.1)
Nutrition and blood 101 (4.4)
Infections 73 (3.2)
Obstetrics, gynaecology and urinary 56 (2.4)
Musculoskeletal 47 (2.0)
Skin 29 (1.3)
Eye 21 (0.9)
Malignancies 15 (0.7)
Ear, nose and oropharynx 5 (0.2)
High-risk drug category (n=412, 17.9%)
Anticoagulants 106 (4.6)
Opiates 85 (3.7)
Diuretics 81 (3.5)
Insulin 63 (2.7)
Antipsychotics 61 (2.7)
Non-steroidal anti-inflammatories 16 (0.7)
BNF, British National Formulary; PERMSS, Pharmacy for
Emergency Repeat Medication Supply Service.
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supplementary file 2). The patient entered the service
by instigating the call to NHS 111, and the successful
exit would be the patient receiving a medication supply
at a community pharmacy. Of these 23 steps, 12 were
identified as adding value, that is, 52.1% of the patient
pathway. Analysis of the pathway revealed fundamental
inefficiencies inherent to the pathway design, resulting
in unnecessary waiting times (2 contributing steps);
duplication of activities (4 steps) and a non-added value
bottleneck. This contributed to the high proportion of
low-value steps, which were likely to have led to the
reported increase in NHS 111 call handling times.
Patient pathway redesign
The current state process map was re-engineered to a
lean thinking system with a redesigned patient pathway
through PERMSS (see online supplementary file 2) to a
future state. This resulted in the reduction of constituent
steps by 30.4% (6 steps); a subsequent increase in steps
adding value to 68.9% (11/16 steps) and reduction in
waste (3 duplication steps and the bottleneck removed).
The process redesign reflected a streamlined employ-
ment of the referral platform to improve the appropriate
use of time and skills of the non-clinical call handlers
and to maximise the contribution of the community
pharmacist in the pathway.
DISCUSSION
PERMSS is a service that responds to a national recom-
mendation for community pharmacy to contribute to
reducing workload pressure on the wider NHS.20 21 It
also meets the recent endorsement by Morecroft et al22
for an NHS-funded emergency supply service. This
evaluation demonstrates that current systems, that is,
NHS 111, PharmOutcomes and the current community
pharmacy regulations for emergency supply medication,
can be adapted and employed to operationalise a
service to direct NHS 111 callers to community phar-
macy. We also show that PERMSS when conservatively
compared with the unit cost of the alternative GP OOH
service offers a more economical option to the NHS for
the management of these patients OOH. This service
not only offers patients a solution for their primary
request, that is, an emergency supply of medication, but
also retains contact with a healthcare professional for
any additional or opportunistic pharmaceutical advice
or service provision. Morecroft et al23 also described
emergency supply requests to community pharmacists as
an opportunity to engage with patients over issues relat-
ing to adherence, medication management and medica-
tion taking via MUR. Further studies also highlight how
contact with community pharmacists provides a time for
opportunistic advice around health promotion and
medication-related issues,24 25 which are a by-product of
a service that directs patients to this healthcare profes-
sional. Our previous study, evaluating PERMSS from the
entry point of self-presenting patients at community
pharmacy OOH with a request for an emergency supply
of repeat medication, detailed results similar to those
reported here in relation to demographics of patients
requiring such a service; timings of highest level of activ-
ity; types of medications requested and levels of high-risk
medications.26 A recent mixed methods evaluation of
patients, pharmacists and GPs perspectives of emergency
supply requests to community pharmacy23 also mirrored
the results of the current study, as many requests are
from the elderly and those with long-term conditions,
but also all age groups are represented among service
users and a diversity in medications requested. Our
study on the self-presenting patients accessing PERMSS
also demonstrated that community pharmacists
expressed support for such a service to be provided
within community pharmacy since it aligned with their
roles and could be accommodated within their daily
activities.26 This service meets both aspects of the busi-
ness versus professional role dichotomy of community
pharmacy, where positive patient outcomes are balanced
with strong business performance.27 As such the support
for its implementation and delivery could be predicted
Table 4 The responses of community pharmacists to the questionnaire items
Survey item
n (%)
Strongly
agree Agree Undecided Disagree
Strongly
disagree
I am clear on the service remit and objectives 121 (54.8) 69 (31.2) 30 (13.6) 1 (0.5) 0
I think this service is aligned to my current competencies,
role and responsibilities
119 (53.8) 67 (30.3) 34 (15.4) 0 1 (0.5)
I think it is appropriate to refer these patients to pharmacy
out of hours
126 (57.0) 58 (26.2) 34 (15.4) 2 (0.9) 1 (0.5)
PharmOutcomes is an appropriate platform for referrals 94 (42.5) 71 (32.1) 39 (17.6) 11 (5.0) 6 (2.7)
The service can be comfortably accommodated within the
current activities of the community pharmacy
94 (42.5) 74 (33.5) 41 (18.6) 11 (5.0) 1 (0.5)
The process of reimbursement is simple 80 (36.2) 67 (30.3) 57 (25.8) 13 (5.9) 4 (1.8)
I am happy to provide this service in community pharmacy 114 (51.6) 74 (33.5) 33 (14.9) 0 0
This service needs improvements 33 (14.9) 65 (29.4) 82 (37.1) 28 (12.7) 13 (5.9)
Nazar H, et al. BMJ Open 2016;6:e011269. doi:10.1136/bmjopen-2016-011269 7
Open Access
 o
n
 31 January 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-011269 on 26 August 2016. Downloaded from 
to be high. Further qualitative data collection from com-
munity pharmacists that probed aspects of the
Normalisation Process Model28 would provide more
information on the barriers and facilitators to the
service implementation and delivery. A consideration of
the ‘completion’ rate presented here is that it may be an
underestimation, as those ‘accepted’, or ‘remain
referred’ may actually have been completed but not
entered onto PharmOutcomes as an additional entry to
normal practice. This limitation is in common with our
previous study26 where a record of emergency supply
may not have been recorded in PharmOutcomes but
instead within the patient medication record and/or in
the private prescription record, as is common practice.
Patients self-presenting for PERMSS expressed high satis-
faction and claimed that this process for obtaining an
emergency supply was more easily accessible compared
to other OOH services.26 This would suggest that NHS
111 referred patients would have had a similar experi-
ence, but specific feedback from this patient group
would be required to investigate the impact of the NHS
111 referral component additional in this patient
journey and is a limitation of this study. However, the
DNA rate of NHS 111 referred patients presenting at
community pharmacy was 3.86% (57 of the 1468
patients referred), which is lower than the reported GP
OOH DNA rates across the North East for the year 2014
(5.56%), which suggests potential patient acceptability
of this service. In our previous study,26 we also discussed
the potential to raise public awareness of the emergency
supply service. The current unease within the commu-
nity pharmacy profession22 may be abated by the intro-
duction of Summary Care Records, allowing pharmacists
to monitor for abuse of accessing this service instead of
attending GP appointments.26
This study does not demonstrate what proportion of
calls to NHS 111 for this disposition were referred to
community pharmacy and therefore redirected away
from urgent and emergency care. These data are crucial
to understand the value of this service in the wider
NHS. Also it is important to understand the motivation
and trust of call advisors in directing callers to commu-
nity pharmacy. Turnball et al found that success of NHS
111 depends on understanding and trusting relation-
ships between the different organisations providing dif-
ferent aspects of the NHS 111 service and managing the
often risk averse CDSS.29
Morecroft et al22 23 provided qualitative and quantita-
tive data on the status quo of emergency supply requests
through community pharmacy and recommended the
initiation of an NHS-funded national emergency supply
service via community pharmacy. This summative service
evaluation provides the descriptive quantitative and
operational data of such a piloted service within the
North East of England. This study does not, however,
explore the perceived added value to the patients in
terms of adherence to their medication regimen or
potential clinical outcomes; benefits suggested by
Morecroft et al.23 The collection of these humanistic and
clinical outcomes, as framed by the economic, clinical
and humanistic outcomes (ECHO) model,30 within
future work alongside the evaluation of the revised
PERMSS would further augment the gravitas and signifi-
cance of this service. Further limitations to this study are
that it does not offer an in-depth understanding of the
service implementation, causal mechanisms to explore
service activity and the context of the delivery and find-
ings. By undertaking a complex evaluation, including a
process evaluation, as framed by the Medical Research
Council guidance,31 the holistic nature of service deli-
very and outcomes would be investigated.
The lean thinking transformation demonstrated a
standardised systematic approach to deconstructing the
constituent elements of a service, understanding and jus-
tifying their significance in the process from the per-
spectives of all stakeholders. This allowed development
of an optimised procedure that could theoretically
improve effectiveness and efficiency. Limitations in the
reporting of the service improvement workshop include
the lack of evaluation that would inform the critical
reader of the context and operation and allow reprodu-
cibility. Despite this, this study follows the NHS recom-
mendations to undertake this exercise to improve and
innovate healthcare service provision. To empirically
substantiate this process, the service activity and stake-
holder feedback subsequent to the implementation and
operation of the newly redesigned future state version of
PERMSS should be evaluated and compared to the
results of this study. This evaluative work is planned fol-
lowing initiation and operation of the newly designed
and commissioned PERMSS.
CONCLUSION
Systems and processes within the operation of NHS 111
can be adapted to direct callers for emergency supply
requests of repeat medication to open community phar-
macies OOH. Current information technology platforms
used by community pharmacy, for example,
PharmOutcomes, can be used to transmit such referrals.
Community pharmacists express support and acceptability
of this process. Patients are directed away from GP OOH
to a contracted NHS healthcare provider for management
of their request and provision of supportive advice and ser-
vices. Lean thinking transformation provided a structured
framework to analyse the current service in terms of the
patient journey and redesign the pathway for potential effi-
ciency and effectiveness. The revised service pathway and
description of the intervention provide a template for
national adoption to allow callers to NHS 111 to be
referred for requests for emergency supplies of their
repeat medication to community pharmacy.
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